dr reddy's glp-1 drugs portfolio 2025 now available as tablets? Semaglutide will now be more accessible than ever as Dr. gets nod to roll out generic oral semaglutide drug, Meryl Dsouza shares all the details Complete Guide to GLP-1 Medications

& Margolis, D

doi: 10.1097/00002281-200207000-00008

There is no intraepidermal melanocytic proliferation

Results at 68 weeks: 40.4% of CagriSema participants lost 25% or more of their body weight 91.9% lost at least 5% Blood pressure fell by 10.9 mmHg systolic on average About 40% of participants reduced or stopped blood pressure medications 87.7% of those with prediabetes at baseline achieved normal blood sugar Results were published in the New England Journal of Medicine and presented at the American Diabetes Associations 2026 Scientific Sessions

It is FDA-approved for type 2 diabetes (FDA-approved 2022)

Because of this impact, your healthcare provider might consider adjusting the dose which may lead to reducing your insulin intake